Hi Bakey, In order to estimate what PAA may one day be worth...

Hi Bakey,
In order to estimate what PAA may one day be worth lets look at the most promising application at the moment. Canine cancer.

• In the us 6 Million dogs get cancer each year. This is easily verifiable on line.
• Current chemo treatments are messy have all the usual side effects and have to be delivered by a Vet in a surgery. Their poo and vomit are toxic [Think cleaning at home] Etc Etc.
• As a result most dogs are euthanized once the disease progresses.
• Monepantel is a toxic free pill that the owner can administer at home.

Assume in 2 or 3 years they have penetrated 50% of the market and each dog provides $2500.00, both are at the lower end of expectations. 3,000,000 X $2500.00 = $7,500,000,000. Now lets be conservative and say $3,500,000,000. With a 10% Royalty coming back to Pharmaust that makes $350,000,000
or earnings of around $1 per share. Lets apply a conservative PE of 10 and you have a 3 Billion dollar company.

And those numbers are all in US dollars.

And that just the Canine Application.

Happy to see alternative arguments but it looks good to me. And is why I expect a T/O during Phase 2 Human tests. NZ posted some stats last year showing the Phase 2 period is when T/Os are most common in bio tech.

Living longer lives exposes our animals to diseases of aging, especially cancer. An estimated 6 million dogs and nearly 6 million cats will be diagnosed with cancer this year.

Includes Diseases: Osteosarcoma; Lymphoma

Quick Pet Cancer Facts and Questions | FETCH a Cure

fetchacure.org › resource-library › facts

All the Best Pete